Archives
Neuroligin 1 Proteolysis and Social Memory
2026-10-08
Liu et al. identify a proteolytic signaling mechanism that helps maintain short-term social memory in mice: social interaction promotes secretase-dependent processing of Neuroligin 1, generating an intracellular fragment that engages cofilin-related synaptic remodeling. The findings provide a mechanistic bridge between social experience, dendritic spine maturation, and memory persistence, while remaining limited by their animal-model and intervention-specific evidence.
METTL16–SENP3–LTF Drives HCC Ferroptosis Resistance
2026-10-08
Wang et al. identify a METTL16–SENP3–LTF regulatory axis that lowers the labile iron pool and protects hepatocellular carcinoma cells from ferroptosis. The study connects RNA modification, protein de-SUMOylation, iron handling, and tumor progression across cellular, organoid, animal, and human-sample evidence, while leaving clinical translation and compound-specific treatment questions open.
IGF2BP1–THBS1–TLR4 Axis in Pulmonary Fibrosis
2026-10-07
A 2025 study identifies an IGF2BP1–THBS1–TLR4 regulatory axis linking m6A-dependent RNA stabilization with macrophage glycolytic reprogramming and fibrotic lung pathology. Its loss-of-function and rescue evidence supports a mechanistic model, while the mouse and cell-based scope limits direct translation to human pulmonary fibrosis.
hUC-MSCs, β-NGF, and Cognitive Recovery After Surgery
2026-10-07
A 2026 CNS Neuroscience & Therapeutics study reports that human umbilical cord mesenchymal stem cells improve surgery-associated cognitive impairment in aged mice through a β-NGF–TrkA–STMN2/NMNAT2–SARM1/NF-κB mechanism. Its multimodal design connects behavioral recovery with reduced hippocampal inflammation, neuronal apoptosis, and dendritic degeneration, while pathway perturbation provides stronger mechanistic support than correlation alone.
TaCRVP Hijacks Tomato Catalase to Suppress Defense
2026-10-06
The 2026 Advanced Science study identifies TaCRVP, a cysteine-rich venom protein from Tuta absoluta oral secretions, as an effector that targets tomato catalase SlCAT2. Its reported dual action—enhancing SlCAT2 activity while limiting its proteasomal turnover—connects insect feeding success with suppression of hydrogen peroxide and jasmonic acid-associated defenses, although transferability beyond the studied tomato–insect system remains to be established.
TCF25, Ferritinophagy, and Lysosomal Cell Death
2026-10-06
Ren et al. identify TCF25 as a nutrient-sensitive regulator that links glucose starvation to lysosomal acidification, autophagic adaptation, and ultimately lysosome-dependent cell death. The study combines genome-wide genetic screening with mechanistic perturbation and a mouse ischemia-reperfusion model, providing a framework for understanding how lysosomes switch from energy-supporting organelles to drivers of injury.
Neticonazole Hydrochloride: Evidence and Limits
2026-10-05
Neticonazole Hydrochloride is an imidazole antifungal with a product-dossier rationale for fungal membrane synthesis inhibition and exploratory colorectal cancer research. The available oncology evidence remains source-limited because the cited peer-reviewed study evaluates a cisplatin/SPION delivery platform rather than neticonazole itself.
HyperScribe™ T7 RNA Labeling Kit: Evidence Guide
2026-10-05
Explore how the HyperScribe™ T7 High Yield Fluorescein RNA Labeling Kit can support conceptual RNA-detection strategies around tomato–Tuta absoluta defense research. This evidence-focused guide separates product relevance from the reported mechanism involving TaCRVP, SlCAT2, hydrogen peroxide, and jasmonic acid signaling.
Redox Immunity and Translational RNA Strategy
2026-10-04
A source-grounded analysis of how Tuta absoluta manipulates tomato redox immunity through the TaCRVP–SlCAT2 axis, what the evidence establishes, where its limits lie, and how fluorescent RNA labeling can support the next generation of translational research questions.
TCF25, Lysosomal Acidification, and Cell Death
2026-10-03
Ren et al. identify TCF25 as a nutrient-responsive regulator that links glucose starvation to V-ATPase-dependent lysosomal acidification, autophagy, ferritinophagy, and lysosome-dependent cell death. The study provides mechanistic insight into metabolic stress and hepatic ischemia-reperfusion injury, while its findings remain preclinical and do not establish a cancer or iron-chelation treatment strategy.
EZ Cap™ CPF1/Cas12a mRNA (m1Ψ) Workflow
2026-10-02
Build transient Cas12a genome-editing assays around T-rich PAM selection, crRNA design, controlled mRNA delivery, and orthogonal editing readouts. This practical guide distinguishes reagent performance from guide, delivery, and DNA-repair effects while outlining troubleshooting paths for R1045 workflows.
CRTC–CREB Sensing of Proteotoxic Stress
2026-10-01
The reference study identifies the CRTC–CREB axis as a stress-responsive transcriptional system that detects proteasome inhibition through ROS and JNK signaling. Using Drosophila, 293T cells, transcriptomics, and Huntington’s disease models, it shows that enhancing CRTC–CREB activity can improve proteostasis and reduce protein aggregation, while also defining the limits of translating these findings to oncology.
Norepinephrine Bitartrate: Translational Precision
2026-10-01
A mechanistic and strategic guide to using (-)-Norepinephrine (+)-bitartrate in adrenergic signaling, cardiomyopathy research, blood pressure regulation, and translational cardiovascular studies, with special attention to salt-formulation reporting and reproducibility.
TCF25, Lysosomal Acidification, and Glucose-Starvation Death
2026-09-30
Ren et al. identify TCF25 as a nutrient-stress regulator that connects glucose starvation to V-ATPase-dependent lysosomal acidification, autophagy, and eventual lysosome-dependent cell death. The study provides a mechanistic framework for distinguishing adaptive lysosomal recycling from maladaptive ferritinophagy and shows that TCF25 deficiency protects against hepatic ischemia-reperfusion injury in mice.
Digoxin: Na+/K+ ATPase Pump Inhibitor Strategy
2026-09-30
A translational framework for using Digoxin to connect Na+/K+ ATPase inhibition with cardiac contractility modulation, arrhythmia treatment research, cell-specific antiviral studies, and disease-state pharmacokinetic design.